Navigation Links
Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
Date:3/30/2009

A Complimentary Webinar

MOUNTAIN VIEW, Calif., March 30 /PRNewswire/ --

     -  TOPIC:      The state of the microRNA market and the molecule's
                    current and potential impact on drug discovery, molecular
                    diagnostics, and personalized therapeutics.
     -  WHEN:       Tuesday, March 31, 2009
     -  TIME:       3 pm EDT
     -  LOCATION:   Online with free registration
     -  HOST:       Christi Bird, Senior Research Analyst, Healthcare
                    practice, Frost & Sullivan
     -  GUESTS:
          -  Dr. George Calin, Associate Professor, The University of Texas
             M. D. Anderson Cancer Center
          -  Alex Amiet, Senior Product Manager, Thermo Fisher Scientific


     -  This panel discussion will benefit life science research tools
        manufacturers, services providers, diagnostic companies,
        biotechnology companies, pharmaceutical companies, academic
        researchers and venture capitalists.  The outlook for the microRNA
        market will be presented from a three-pronged perspective of an
        industry analyst with knowledge of the market, a microRNA expert
        from academia, and a provider of microRNA tools and services.

Supporting Quote

"The rapid discoveries linking microRNAs to various diseases have propelled the microRNA field and tools market in recent years. Moving forward, however, the microRNA field requires more innovative studies of larger scope to make good on its lofty promise," says Bird of Frost & Sullivan.

Supporting Resources

To participate, please email Stephanie Ochoa, stephanie.ochoa@frost.com, with the following information: your full name, title, company name, company telephone number, company email address, city, state and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

Frost & Sullivan's Drug Discovery practice: www.frost.com/drugdiscovery

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Stephanie Ochoa
    Frost & Sullivan
    +1.210.247.2421
    stephanie.ochoa@frost.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Award Highlights Opportunity for Main Street Biotech
2. Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
3. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
4. Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
5. Frost & Sullivan: In Vitro Diagnostics Market
6. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
7. Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG
8. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
9. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
10. Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
11. Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... and NEW YORK , Feb. ... Lumeon , a leading digital health company, and ... provider of telemedicine and remote patient monitoring, announce ... telemedicine reimbursements.  DN Telehealth maximizes ... in real-time, extending consultations beyond a physical clinical ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® ... adults at home or in healthcare facilities during periods of rest. A lightweight, ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, Inc ... with Compass Research . GGI's mission is to advance global health and highlight ... in need in honor of each clinical trial volunteer. The vision of GGI is ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):